Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Metabolic tumor volume as a prognostic imaging-based biomarker for head-and-neck cancer: pilot results from Radiation Therapy Oncology Group protocol 0522.

International journal of radiation oncology, biology, physics - 15 Mar 2015

Schwartz David L, Harris Jonathan, Yao Min, Rosenthal David I, Opanowski Adam, Levering Anthony, Ang K Kian, Trotti Andy M, Garden Adam S, Jones Christopher U, Harari Paul, Foote Robert, Holland John, Zhang Qiang, Le Quynh-Thu

Abstract excerpt

PURPOSE: To evaluate candidate fluorodeoxyglucose positron emission tomography/computed tomography (FDG-PET/CT) imaging biomarkers for head-and-neck chemoradiotherapy outcomes in the cooperative group trial setting. METHODS AND MATERIALS: Radiation Therapy Oncology Group (RTOG) protocol 0522 pati...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Chemoradiotherapy
Share to Confidence Intervals

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Fluorodeoxyglucose F18

Share to Laryngeal Neoplasms

Share to Lymphatic Metastasis

Share to Oropharyngeal Neoplasms

Share to Positron-Emission Tomography

Share to Radiopharmaceuticals

Source

Open in PubMed Open full text

Identifiers

PMID: 25752384
DOI: 10.1016/j.ijrobp.2014.12.023
PMCID: PMC4672942

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026. Prepared record publication-25752384-2026-09-04.2. Manifest publication-graph-cohort-2026-09-04.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 9 closest

Metabolic tumor volume as a prognostic imaging-based biomarker for head-and-neck cancer: pilot results from Radiation Therapy Oncology Group protocol 0522.PMID 25752384Read ↗

Prognostic significance of integrating total metabolic tumor volume and EGFR mutation status in patients with lung adenocarcinoma.Semantic proximity Read ↗

Establishment and Validation of a Nomogram with Intratumoral Heterogeneity Derived from 18F-FDG PET/CT for Predicting Individual Conditional Risk of 5-Year Recurrence before Initial Treatment of Nasopharyngeal CarcinomaSemantic proximity Read ↗

Baseline Suvmax Correlates with Tumor Hypoxia and Patient Outcomes in Nasopharyngeal Carcinoma: Employing Transcriptomic Gene Signature AnalysisSemantic proximity Read ↗

Relationship between tumor mutational burden and maximum standardized uptake value in 2-[18F]FDG PET (positron emission tomography) scan in cancer patientsSemantic proximity Read ↗

Primary metabolic tumor volume from 18F-FDG PET/CT associated with epidermal growth factor receptor mutation in lung adenocarcinoma patients.Semantic proximity Read ↗

Volumetric PET parameters can predict overall survival in advanced lung adenocarcinoma.Semantic proximity Read ↗

Molecular PET imaging for biology-guided adaptive radiotherapy of head and neck cancerSemantic proximity Read ↗

Exploring quantitative MRI biomarkers of head and neck post-radiation lymphedema and fibrosis: Post hoc analysis of a prospective trialSemantic proximity Read ↗

Correlation of PET images of metabolism, proliferation and hypoxia to characterize tumor phenotype in patients with cancer of the oropharynx.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.